Edesa Biotech, Inc. Weighted Average Number of Shares Outstanding, Basic from 2013 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Edesa Biotech, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2013 to Q2 2025.
  • Edesa Biotech, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2025 was 7.02M shares, a 118% increase year-over-year.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 3.2M shares, a 11.8% increase from 2023.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.86M shares.
  • Edesa Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2016 was 8.83M shares, a 10.9% increase from 2015.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Edesa Biotech, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 7.02M +3.8M +118% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 5.31M +2.11M +66.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 3.35M +217K +6.94% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 3.2M Jul 1, 2024 Sep 30, 2024 10-K 2024-12-13
Q2 2024 3.22M +291K +9.93% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 3.19M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 3.13M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
Q2 2023 2.93M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q2 2016 8.45M +494K +6.21% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q3 2015 7.96M +89.4K +1.14% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 7.95M -68.3M -89.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 79.5M +3.31M +4.34% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 79.5M +5.48M +7.41% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-09
Q3 2014 7.87M Sep 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 76.2M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 76.2M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 74M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09

Edesa Biotech, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 3.2M +338K +11.8% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-13
2023 2.86M Oct 1, 2022 Sep 30, 2023 10-K 2024-12-13
2016 8.83M +869K +10.9% Oct 1, 2015 Sep 30, 2016 10-K 2016-12-14
2015 7.96M +374K +4.94% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-14
2014 7.58M +2.42M +46.9% Sep 1, 2013 Aug 31, 2014 10-K 2016-12-14
2013 5.16M Sep 1, 2012 Aug 31, 2013 10-K 2015-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.